2m 2m 2m 2m 2m 2m 2m
IMMUNEERING-A (IMRX)
NASDAQ
$5.03-$0.13 (-2.50%)
Price as of Jul 14, 2026 4:26 AM EDT- $330.6MMarket Cap
- 23.74%1-Year Change
- BiotechnologyIndustry
IMMUNEERING-A (IMRX)
$5.03-$0.13 (-2.50%)
IMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.16 | ||
Change | +$0.05 (+0.98%) | ||
Open | $5.07 | ||
High | $5.17 | ||
Low | $4.93 | ||
Previous Close | $5.11 | ||
Volume | 703,973 | ||
30-Day Average Volume | 1,531,839 | ||
1-Week Change | 0.39% | ||
1-Month Change | 23.15% | ||
1-Year Change | 23.74% | ||
3-Year Change | -45.57% | ||
5-Year Change | 9,747.33% | ||
Fundamentals | |||
Shares Outstanding | 64.7M | ||
Total Assets | $214.8M | ||
Market Cap | $330.6M | ||
Enterprise Value | $283.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.5M | ||
Free Cash Flow | -$18.5M | ||
EBIT | -$13.5M | ||
EBITDA | -$13.5M | ||
Net Working Capital | $156.4M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -24 | ||
PEG | 1 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue